Susquehanna Fundamental Investments’s Compugen CGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
$312K Sell
97,006
-21,019
-18% -$71K 0.01% 1251
2021
Q4
$508K Buy
118,025
+17,656
+18% +$95.5K 0.01% 907
2021
Q3
$599K Buy
100,369
+39,069
+64% +$262K 0.01% 1114
2021
Q2
$508K Buy
+61,300
New +$498K 0.01% 1160
2021
Q1
Sell
-10,002
Closed -$121K 1537
2020
Q4
$121K Sell
10,002
-89,198
-90% -$1.23M ﹤0.01% 1408
2020
Q3
$1.61M Buy
99,200
+300
+0.3% +$4.92K 0.05% 499
2020
Q2
$1.49M Buy
+98,900
New +$1.33M 0.07% 358

Other funds holding CGEN

Susquehanna Fundamental Investments's CGEN Position: Q1 2022 in Review

Susquehanna Fundamental Investments reduced its Compugen (CGEN) stake by 18% in Q1 2022, selling an estimated $71K and leaving 97,006 shares worth $312K. The position accounts for 0.01% of the portfolio, ranked #1251.

Susquehanna Fundamental Investments first reported a position in CGEN in Q2 2020 and has held it in 7 quarters since. The position peaked at $1.61M in Q3 2020. 110 funds tracked by Wall St. Rank hold CGEN as of Q1 2022.

  • Susquehanna Fundamental Investments held 97,006 shares of Compugen worth $312K as of Q1 2022.
  • Susquehanna Fundamental Investments sold 21,019 Compugen shares in Q1 2022, an estimated $71K.
  • Compugen made up 0.01% of Susquehanna Fundamental Investments's portfolio in Q1 2022, its #1251 holding.
  • Susquehanna Fundamental Investments first reported a position in Compugen in Q2 2020 and has held it in 7 quarters since.
  • Susquehanna Fundamental Investments's Compugen position peaked at $1.61M in Q3 2020.
  • 110 funds tracked by Wall St. Rank held Compugen as of Q1 2022.

Based on Susquehanna Fundamental Investments's 13F filing for Q1 2022, filed 16 May 2022.